News

Markison will also be a member of the board of the newly created standalone company, following the completion of the acquisition of Nycomed A/S by Takeda Pharmaceuticals. Previously,

The contracts are part of an ongoing effort to develop diagnostic tools and drugs to protect health and save lives in a radiological or nuclear emergency such as

The company expects to recruit patients in 70 centers in 11 European nations. In the trial, the preterm infants younger than 32 weeks of gestational age are randomized

Ridaforolimus is an investigational mTOR inhibitor being developed by Merck that has completed a Phase 3 clinical trial in patients with soft-tissue and bone sarcomas and is being

Livatag, which has been awarded orphan drug status in Europe and US, is a treatment presented in nanoparticles able to deliver doxorubicin in chemoresistant cells. The production for

The products include Neo-Polycin; Neo-Polycin HC; Polycin; Neomycin and Polymyxin B Sulfates with Dexamethasone Ophthalmic Ointments. Fera president Frank DellaFera said achieving this important milestone for their company,

Capsugel is a provider of drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel provides array of products and services, from hard gelatin, vegetarian

StayinFront is a global provider of CRM systems and mobile sales force effectiveness tools. Using StayinFront CRM systems, which run on AdvantageMS National Provider Database, users can have

ALN-VSP is a systemically delivered RNAi therapeutic which includes two siRNAs intended to target two genes critical for the growth and development of cancer cells: vascular endothelial growth